Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Signal Transduction Signaling Pathway G Protein Signaling Small G Proteins Other

Anti-Insulin degrading enzyme / IDE antibody [EPR6099] (ab109538)

Price and availability

338 390 ₸

Availability

Order now and get it on Wednesday March 10, 2021

Anti-Insulin degrading enzyme / IDE antibody [EPR6099] (ab109538)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)
  • ChIP - Anti-Histone H3 antibody - Nuclear Loading Control and ChIP Grade (ab1791)

Key features and details

  • Produced recombinantly (animal-free) for high batch-to-batch consistency and long term security of supply
  • Rabbit monoclonal [EPR6099] to Insulin degrading enzyme / IDE
  • Suitable for: WB, Flow Cyt
  • Knockout validated
  • Reacts with: Mouse, Human

You may also be interested in

Product image
Recombinant Human S100A14 protein (His tag) (ab221403)
Recombinant Human SCGF protein (Tagged) (ab198771)
Product image
Thymidine Kinase 1 overexpression 293T lysate (whole cell) (ab94157)
Product image
Anti-DHX36 antibody (ab70269)

Overview

  • Product name

    Anti-Insulin degrading enzyme / IDE antibody [EPR6099]
    See all Insulin degrading enzyme / IDE primary antibodies
  • Description

    Rabbit monoclonal [EPR6099] to Insulin degrading enzyme / IDE
  • Host species

    Rabbit
  • Tested Applications & Species

    Application Species
    Flow Cyt
    Human
    WB
    Human
    See all applications and species data
  • Immunogen

    Synthetic peptide. This information is proprietary to Abcam and/or its suppliers.

  • Positive control

    • WB: HAP1, HeLa, HepG2, A375, and K562 cell lysates
  • General notes

    This product is a recombinant monoclonal antibody, which offers several advantages including:

    • - High batch-to-batch consistency and reproducibility
    • - Improved sensitivity and specificity
    • - Long-term security of supply
    • - Animal-free production
    For more information see here.

    Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.

Properties

  • Form

    Liquid
  • Storage instructions

    Shipped at 4°C. Store at +4°C short term (1-2 weeks). Upon delivery aliquot. Store at -20°C. Stable for 12 months at -20°C.
  • Storage buffer

    pH: 7.20
    Preservative: 0.05% Sodium azide
    Constituents: 0.1% BSA, 40% Glycerol (glycerin, glycerine), 9.85% Tris glycine, 50% Tissue culture supernatant
  • Concentration information loading...
  • Purity

    Tissue culture supernatant
  • Clonality

    Monoclonal
  • Clone number

    EPR6099
  • Isotype

    IgG
  • Research areas

    • Neuroscience
    • Neurology process
    • Neurodegenerative disease
    • Alzheimer's disease
    • Other
    • Signal Transduction
    • Growth Factors/Hormones
    • Insulin / Insulin-like
    • Neuroscience
    • Neurology process
    • Metabolism
    • Cell Biology
    • Proteolysis / Ubiquitin
    • Proteolytic enzymes
    • Metalloprotease
    • Insulysin
    • Cardiovascular
    • Atherosclerosis
    • Diabetes associated
    • Metabolism
    • Types of disease
    • Neurodegenerative disease
    • Metabolism
    • Types of disease
    • Diabetes
    • Metabolism
    • Types of disease
    • Cancer
    • Metabolism
    • Types of disease
    • Heart disease

Images

  • Western blot - Anti-Insulin degrading enzyme / IDE antibody [EPR6099] (ab109538)
    Western blot - Anti-Insulin degrading enzyme / IDE antibody [EPR6099] (ab109538)
    All lanes : Anti-Insulin degrading enzyme / IDE antibody [EPR6099] (ab109538) at 1/1000 dilution

    Lane 1 : Wild-type HeLa cell lysate
    Lane 2 : IDE knockout HeLa cell lysate

    Lysates/proteins at 20 µg per lane.

    Performed under reducing conditions.

    Predicted band size: 118 kDa
    Observed band size: 118 kDa



    Lanes 1- 2: Merged signal (red and green). Green - ab109538 observed at 118 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.

     ab109538 was shown to react with Insulin degrading enzyme / IDE in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab261755 (knockout cell lysate ab257197) was used. Wild-type HeLa and IDE knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab109538 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.

  • Flow Cytometry - Anti-Insulin degrading enzyme / IDE antibody [EPR6099] (ab109538)
    Flow Cytometry - Anti-Insulin degrading enzyme / IDE antibody [EPR6099] (ab109538)

    Flow Cytometry analysis of HeLa (human cervix adenocarcinoma) cells labeling Insulin degrading enzyme / IDE with purified ab109538 at 1/150 dilution (10ug/ml) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. A Goat anti-rabbit IgG (Alexa Fluor® 488)(1/2000 dilution) was used as the secondary antibody. Rabbit monoclonal IgG (Black) was used as the isotype control, cells without incubation with primary antibody and secondary antibody (Blue) were used as the unlabeled control.

  • Western blot - Anti-Insulin degrading enzyme / IDE antibody [EPR6099] (ab109538)
    Western blot - Anti-Insulin degrading enzyme / IDE antibody [EPR6099] (ab109538)
    All lanes : Anti-Insulin degrading enzyme / IDE antibody [EPR6099] (ab109538) at 1/2000 dilution

    Lane 1 : Wild-type HAP1 cell lysate
    Lane 2 : IDE knockout HAP1 cell lysate
    Lane 3 : K562 cell lysate
    Lane 4 : HepG2 cell lysate

    Lysates/proteins at 20 µg per lane.

    Predicted band size: 118 kDa



    Lanes 1 - 4: Merged signal (red and green). Green - ab109538 observed at 118 kDa. Red - loading control, ab8245, observed at 37 kDa.


    ab109538 was shown to specifically react with IDE in wild-type HAP1 cells. No band was observed when IDE knockout samples were examined. Wild-type and IDE knockout samples were subjected to SDS-PAGE. ab109538 and ab8245 (loading control to GAPDH) were both diluted 1/2000 and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed ab216776 secondary antibodies at 1/10,000 dilution for 1 hour at room temperature before imaging.

  • Western blot - Anti-Insulin degrading enzyme / IDE antibody [EPR6099] (ab109538)
    Western blot - Anti-Insulin degrading enzyme / IDE antibody [EPR6099] (ab109538)
    All lanes : Anti-Insulin degrading enzyme / IDE antibody [EPR6099] (ab109538) at 1/10000 dilution

    Lane 1 : HeLa cell lysate
    Lane 2 : HepG2 cell lysate
    Lane 3 : A375 cell lysate
    Lane 4 : K562 cell lysate

    Lysates/proteins at 10 µg per lane.

    Secondary
    All lanes : HRP-labelled goat anti-rabbit at 1/2000 dilution

    Predicted band size: 118 kDa

  • Anti-Insulin degrading enzyme / IDE antibody [EPR6099] (ab109538)
    Anti-Insulin degrading enzyme / IDE antibody [EPR6099] (ab109538)

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Alternative products to Anti-Insulin degrading enzyme / IDE antibody [EPR6099] (ab109538)

  •  
  • Product image

    Anti-Insulin degrading enzyme / IDE antibody - N-terminal (ab228671)

    Applications: WB

  •  
  • Product image

    Anti-Insulin degrading enzyme / IDE antibody [EPR6098(2)] (ab133561)

    Applications: IHC-P, WB

  •  
  • Product image

    Anti-Insulin degrading enzyme / IDE antibody (ab32216)

    Applications: IHC-FoFr, WB

  •  
  • Product image

    Anti-Insulin degrading enzyme / IDE antibody [EPR6098(2)] - BSA and Azide free (ab233020)

    Applications: IHC-P, WB

  •  
  • Product image

    Anti-Insulin degrading enzyme / IDE antibody (ab228720)

    Applications: ICC/IF, IHC-P, WB

  •  
  • Product image

    Anti-Insulin degrading enzyme / IDE antibody (ab228601)

    Applications: WB

  •  
  • Product image

    HRP Anti-Insulin degrading enzyme / IDE antibody [EPR6099] (ab201836)

    Applications: WB

  •  
  • Product image

    Anti-Insulin degrading enzyme / IDE antibody (ab245521)

    Applications: WB

Clear all

Recently viewed products

  •  
  • Product image

    Anti-Glutamate Receptor 1 (AMPA subtype) antibody [EPR5479] (ab109450)

  •  
  • Product image

    Anti-Eph receptor B1/NET antibody [EPR6457] (ab129103)

  •  
  • Product image

    Anti-IQGAP1 antibody [EPR5220] - BSA and Azide free (ab271893)

  •  
  • Product image

    Human CHIT1 ELISA Kit (ab246541)

  •  
  • Product image

    Anti-POLDIP2 antibody [EPR13832] - BSA and Azide free (ab232609)

  •  
  • Product image

    Anti-Granzyme B antibody [EPR8260] - BSA and Azide free (ab226162)

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.